Market Cap 513.67M
Revenue (ttm) 200.45M
Net Income (ttm) -6.02M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -3.00%
Debt to Equity Ratio 0.00
Volume 1,176,000
Avg Vol 849,954
Day's Range N/A - N/A
Shares Out 128.10M
Stochastic %K 4%
Beta 1.42
Analysts Sell
Price Target $7.05

Latest News on CTKB

Upgrading Cytek Biosciences Stock On An Upcoming Catalyst

Jan 9, 2025, 9:30 AM EST - 2 months ago

Upgrading Cytek Biosciences Stock On An Upcoming Catalyst


Cytek Biosciences, Inc. (CTKB) Q3 2024 Earnings Call Transcript

Nov 5, 2024, 8:26 PM EST - 5 months ago

Cytek Biosciences, Inc. (CTKB) Q3 2024 Earnings Call Transcript


Cytek Biosciences, Inc. (CTKB) Q2 2024 Earnings Call Transcript

Aug 11, 2024, 4:25 AM EDT - 8 months ago

Cytek Biosciences, Inc. (CTKB) Q2 2024 Earnings Call Transcript


Cytek Biosciences, Inc. (CTKB) Q1 2024 Earnings Call Transcript

May 12, 2024, 3:24 AM EDT - 11 months ago

Cytek Biosciences, Inc. (CTKB) Q1 2024 Earnings Call Transcript


Cytek Biosciences Reports First Quarter 2024 Financial Results

May 8, 2024, 4:05 PM EDT - 11 months ago

Cytek Biosciences Reports First Quarter 2024 Financial Results


Cytek Biosciences: Undisputed Next-Gen Flow Cytometry Leader

Mar 20, 2024, 4:33 AM EDT - 1 year ago

Cytek Biosciences: Undisputed Next-Gen Flow Cytometry Leader


Cytek Biosciences, Inc. (CTKB) Q3 2023 Earnings Call Transcript

Nov 11, 2023, 10:56 AM EST - 1 year ago

Cytek Biosciences, Inc. (CTKB) Q3 2023 Earnings Call Transcript